Pharmxnext - Due diligence report

A 360° intelligence report on Pharmxnext: trust score, financial health, credit view, compliance, directors, growth and distress signals - g…

2017-07-05 Thane, Maharashtra Active
Share
Connect MCP
PH Pharmxnext
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Pharmxnext — 360° Intelligence Report

Generated from MCA filings & public records
86/100
Trust Score
Low Risk

Pharmxnext is assessed as Low Risk with a Trust Score of 86/100. Pharmxnext is an active limited liability partnership incorporated in 2017, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 09 Oct 2026 from the latest processed filings. Pharmnxt Biotech Llp snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
86/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
75/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
65/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
90/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 4 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 65/100 Moderate
  • Profitable - internal accruals available.

Charges position: 4 open (9.27 cr) · 1 satisfied (4.61 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Yes Bank Limited1 48.0 cr
Indusind Bank Ltd.1 48.0 cr
Hdfc Bank Limited3 48.0 cr
Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
  • 3 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
NANDKUMAR VASANT THAKARE 01234567 Director 01/04/2018 6 yrs Approved
SACHIN SATISH JOSHI 01234567 Director 01/04/2018 6 yrs Approved
ANKUSH KAPOOR 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 90 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +38% over 3 year(s).
Latest year revenue grew 1.42.
Asset base grew 2.1x - capacity expansion.
EPFO headcount growing - hiring signal.
Operating for 9 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
4 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence88/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment74/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 4 open charge(s) of 9.27 cr already registered.
  • Compliance record supports lending.
Investor view84/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 4 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
06 Jun 2025
Charge created
Hdfc Bank Limited - 17.50 Lakh
28 May 2025
Charge created
Hdfc Bank Limited - 20.99 Lakh
31 Mar 2025
Last AGM held
Annual general meeting
Latest balance sheet
Filed with ROC
27 Feb 2025
Charge satisfied
Indusind Bank Ltd.
28 Dec 2024
Charge created
Yes Bank Limited - 8.40 cr
31 Mar 2022
Charge created
Hdfc Bank Limited - 48.59 Lakh
14 May 2021
Director ceased
AMOD DINKAR PANDIT
28 Apr 2021
Charge created
Indusind Bank Ltd. - 4.61 cr
01 Apr 2021
Director appointed
NANDKUMAR VASANT THAKARE (Designated Partner)
Director appointed
SACHIN SATISH JOSHI (Designated Partner)
Director ceased
TANUJA NANDKUMAR THAKARE
01 Mar 2018
Director ceased
NIRMAL AMOD PANDIT
05 Jul 2017
Incorporated
Registered with Roc Mumbai
Director appointed
ANKUSH KAPOOR (Designated Partner)
10

Key Observations

Auto-generated from the data above
Revenue grew 24% over the last 3 financial year(s).
Net profit margin moved from 0.86 to 61%.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
3 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
1 overseas direct investment(s) (ODI) on record - international footprint.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Opus Dei Logistics (India) Private Limited U74900MH2010PTC204784 Thane, Maharashtra
Mabas Marine Private Limited U74999MH2018PTC309467 Thane, Maharashtra
CORNERSTONE TRANS LLP AAU-7968 Thane, Maharashtra
Signifikant Software Solutions Private Limited U72900MH2006PTC164311 Thane, Maharashtra
Evse Ready India Private Limited U50400MH2019PTC333349 Thane, Maharashtra
SKKYDALE INFRAVENTURE LLP ACA-8249 Thane, Maharashtra
Compel Consultancy Private Limited U74999MH2012PTC231303 Thane, Maharashtra
Sculpting Careers Private Limited U74999MH2023PTC397727 Thane, Maharashtra
Veruno India Private Limited U26960MH2013PTC249187 Thane, Maharashtra
HYDERABAD INFRASTRUCTURES PRIVATE LIMITED U70102MH2013PTC245979 Thane, Maharashtra
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Pharmxnext before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Pharmxnext: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 65/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 90/100, margin trends, ownership structure and peer set for Pharmxnext - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 86/100, distress signals and MSME payment-delay disclosures - know whether Pharmxnext pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Pharmxnext - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Pharmxnext an active company?

Pharmxnext has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Pharmxnext financially healthy?

Pharmxnext has a Financial Health Score of 75/100 (Low Risk) based on its filed financial statements.

Should I do business with Pharmxnext?

Its overall Trust Score is 86/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Pharmxnext?

See the directors and ownership sections above for board and shareholding detail. 3 active director(s) are on record.

Does Pharmxnext have loans or charges against its assets?

4 open charge(s) are registered against its assets, and 1 earlier charge(s) stand satisfied.

Is Pharmxnext up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Pharmxnext?

Its Credit Risk Score is 65/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.